Sign in
4

Changes in Ownership

FATE THERAPEUTICS INC Filed Acc 0001193125-26-271083

Options or other derivatives

  • Director acquired 87,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
EPSTEIN ROBERT S Director 2026-06-12 Grant or award · Stock Option (Right to Buy) +87,900 87,900 D
Loading xslF345X06/ownership.xml…